427
Views
42
CrossRef citations to date
0
Altmetric
Original Research

Co-Delivery of Prednisolone and Curcumin in Human Serum Albumin Nanoparticles for Effective Treatment of Rheumatoid Arthritis

, , , , , & show all
Pages 9113-9125 | Published online: 22 Nov 2019

References

  • Lu W, Zhou Z, Naqvi SMAS, Li X. Meta-analysis on efficacy and safety of modified guizhi shaoyao zhimu tang with the western medicines in treating rheumatoid arthritis. Yangtze Med. 2018;02:161–170. doi:10.4236/ym.2018.23017
  • Wang Q, Jiang H, Li Y, et al. Targeting NF-kB signaling with polymeric hybrid micelles that co-deliver siRNA and dexamethasone for arthritis therapy. Biomaterials. 2017;122:10–22. doi:10.1016/j.biomaterials.2017.01.00828107661
  • Crielaard BJ, Rijcken CJF, Quan L, et al. Glucocorticoid-loaded core-cross-linked polymeric micelles with tailorable release kinetics for targeted therapy of rheumatoid arthritis. Angew Chem Int Ed. 2012;51:7254–7258. doi:10.1002/anie.201202713
  • Feldmann M, Maini SRN. Role of cytokines in rheumatoid arthritis an education in pathophysiology and therapeutics. Immunol Rev. 2008;223:7–19. doi:10.1111/j.1600-065X.2008.00626.x18613827
  • Gerli R, Pitzalis C, Lunardi C. The role of T cell cytokines in modulating joint inflammation in rheumatoid arthritis. IMAJ. 2002;4:949–952.12455188
  • Jain S, Tran TH, Amiji M. Macrophage repolarization with targeted alginate nanoparticles containing IL-10 plasmid DNA for the treatment of experimental arthritis. Biomaterials. 2015;61:162–177. doi:10.1016/j.biomaterials.2015.05.02826004232
  • Li C, Li H, Wang Q, et al. pH-sensitive polymeric micelles for targeted delivery to inflamed joints. J Control Release. 2017;246:133–141. doi:10.1016/j.jconrel.2016.12.02728038947
  • Wang Q, Jiang J, Chen W, et al. Targeted delivery of low-dose dexamethasone using PCL-PEG micelles for effective treatment of rheumatoid arthritis. J Control Release. 2016;230:64–72. doi:10.1016/j.jconrel.2016.03.03527057749
  • Zhou M, Hou J, Zhong Z, et al. Targeted delivery of hyaluronic acid-coated solid lipid nanoparticles for rheumatoid arthritis therapy. Drug Deliv. 2018;25:716–722. doi:10.1080/10717544.2018.144705029516758
  • Wang Q, Sun X. Recent advances in nanomedicines for the treatment of rheumatoid arthritis. Biomater Sci. 2017;5:1407–1420. doi:10.1039/C7BM00254H28631779
  • Quan L, Zhang Y, Crielaard BJ, et al. Nanomedicines for inflammatory arthritis: head-tohead comparison of glucocorticoid-containing polymers, micelles, and liposomes. ACS Nano. 2013;8:458–466. doi:10.1021/nn404820524341611
  • Chuan YP, Zeng BY, O’Sullivan B, et al. Co-delivery of antigen and a lipophilic anti-inflammatory drug to cells via a tailorable nanocarrier emulsion. J Colloid Interface Sci. 2012;368:616–624. doi:10.1016/j.jcis.2011.11.01422153851
  • Shakibaei M, Schulze-Tanzil G, John T, et al. Curcumin protects human chondrocytes from IL-1β-induced inhibition of collagen type II and β1-integrin expression and activation of caspase-3: an immunomorphological study. Ann Anat. 2005;187:487–497. doi:10.1016/j.aanat.2005.06.00716320828
  • Mollazadeh H, Cicero AFG, Blesso CN, et al. Immune modulation by curcumin: the role of interleukin-10. Crit Rev Food Sci Nutr. 2019;59:89–101. doi:10.1080/10408398.2017.135813928799796
  • Ahn JK, Kim S, Hwang J, et al. Metabolomic elucidation of the effects of curcumin on fibroblast-like synoviocytes in rheumatoid arthritis. PLoS One. 2015;10:1–15. doi:10.1371/journal.pone.0145539
  • Arora R, Kuhad A, Kaur IP, Chopra K. Curcumin loaded solid lipid nanoparticles ameliorate adjuvant-induced arthritis in rats. Eur J Pain. 2015;19:940–952. doi:10.1002/ejp.62025400173
  • Banji D, Pinnapureddy J, Banji OJ, et al. Synergistic activity of curcumin with methotrexate in ameliorating Freund’s Complete Adjuvant induced arthritis with reduced hepatotoxicity in experimental animals. Eur J Pharmacol. 2011;668:293–298. doi:10.1016/j.ejphar.2011.06.00621693118
  • Kratz F. A clinical update of using albumin as a drug vehicle - a commentary. J Control Release. 2014;190:331–336. doi:10.1016/j.jconrel.2014.03.01324637463
  • Yi X, Lian X, Dong J, et al. Co-delivery of pirarubicin and paclitaxel by human serum albumin nanoparticles to enhance antitumor effect and reduce systemic toxicity in breast cancers. Mol Pharm. 2015;12:4085–4098. doi:10.1021/acs.molpharmaceut.5b0053626422373
  • Elzoghby AO, Samy WM, Elgindy NA. Albumin-based nanoparticles as potential controlled release drug delivery systems. J Control Release. 2012;157:168–182. doi:10.1016/j.jconrel.2011.07.03121839127
  • Elsadek B, Kratz F. Impact of albumin on drug delivery - new applications on the horizon. J Control Release. 2012;157:4–28. doi:10.1016/j.jconrel.2011.09.06921959118
  • Prasad LK, O’Mary H, Cui Z. Nanomedicine delivers promising treatments for rheumatoid arthritis. Nanomedicine. 2015;10:2063–2074. doi:10.2217/nnm.15.4526084368
  • Wang D, Miller SC, Liu X-M, et al. Novel dexamethasone-HPMA copolymer conjugate and its potential application in treatment of rheumatoid arthritis. Arthritis Res Ther. 2007;9(1):R2. doi:10.1186/ar210617233911
  • Wang Q, Li Y, Chen X, et al. Optimized in vivo performance of acid-liable micelles for the treatment of rheumatoid arthritis by one single injection. Nano Res. 2018;12:421–428. doi:10.1007/s12274-018-2233-3
  • Wang Y, Liu Z, Li T, et al. Enhanced therapeutic effect of RGD-modified polymeric micelles loaded with low-dose methotrexate and nimesulide on rheumatoid arthritis. Theranostics. 2019;9:708–720. doi:10.7150/thno.3041830809303
  • Quan LD, Purdue PE, Liu XM, et al. Development of a macromolecular prodrug for the treatment of inflammatory arthritis: mechanisms involved in arthrotropism and sustained therapeutic efficacy. Arthritis Res Ther. 2010;12:R170. doi:10.1186/ar313020836843
  • Fasano M, Curry S, Terreno E, et al. The extraordinary ligand binding properties of human serum albumin. IUBMB Life. 2005;57:787–796. doi:10.1080/1521654050040409316393781
  • Tao-Tao T, Lin-Li L, Wang B, et al. Employing macrophage-derived microvesicle for kidney-targeted delivery of dexamethasone: an efficient therapeutic strategy agaist renal inflammation and fibrosis. Theranostics. 2019;16:4740–4755.
  • Yang M, Feng X, Ding J, Chang F, Chen X. Nanotherapeutics relieve rheumatoid arthritis. J Control Release. 2017;252:108–124. doi:10.1016/j.jconrel.2017.02.03228257989
  • Yuan F, Quan LD, Cui L, et al. Development of macromolecular prodrug for rheumatoid arthritis. Adv Drug Deliv Rev. 2012;64:1205–1219. doi:10.1016/j.addr.2012.03.00622433784
  • Metselaar JM, Den Berg WB, Holthuysen AE, et al. Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis. Ann Rheum Dis. 2004;63(4):348–353. doi:10.1136/ard.2003.00994415020326
  • He W, Lv Y, Zhao Y, et al. Core-shell structured gel-nanocarriers for sustained drug release and enhanced antitumor effect. Int J Pharm. 2015;484(1–2):163–171. doi:10.1016/j.ijpharm.2015.02.05325724136
  • Manca ML, Lattuada D, Valenti D, et al. Potential therapeutic effect of curcumin loaded hyalurosomes against inflammatory and oxidative processes involved in the pathogenesis of rheumatoid arthritis: the use of fibroblast-like synovial cells cultured in synovial fluid. Eur J Pharm Biopharm. 2019;136:84–92. doi:10.1016/j.ejpb.2019.01.01230659893
  • Manca ML, Castangia I, Zaru M, et al. Development of curcumin loaded sodium hyaluronate immobilized vesicles (hyalurosomes) and their potential on skin inflammation and wound restoring. Biomaterials. 2015;71:100–109. doi:10.1016/j.biomaterials.2015.08.03426321058
  • Kinne W, Brauer R, Stuhlmuller B, Palombo-Kinne E, Burmeste G. Macrophages in rheumatoid arthritis. Arthritis Res. 2000;2:2189–2202. doi:10.1186/ar86
  • Lawrence T, Natoli G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol. 2011;11:750–761. doi:10.1038/nri308822025054
  • Sundar Dhilip Kumar S, Houreld NN, Abrahamse H. Therapeutic potential and recent advances of curcumin in the treatment of aging-associated diseases. Molecules. 2018;23(4):835–849. doi:10.3390/molecules23040835
  • Zheng Z, Sun Y, Liu Z, et al. The effect of curcumin and its nanoformulation on adjuvant-induced arthritis in rats. Drug Des Devel Ther. 2015;9:4931–4942. doi:10.2147/DDDT.S90147
  • Khalifé S, Zafarullah M. Molecular targets of natural health products in arthritis. Arthritis Res Ther. 2011;13:102–105. doi:10.1186/ar322221345249
  • Zhao H, Lu H, Gong T, et al. Nanoemulsion loaded with lycobetaine-oleic acid ionic complex: physicochemical characteristics, in vitro, in vivo evaluation, and antitumor activity. Int J Nanomed. 2013;8:1959–1973.